Treatment of Massive or Submassive Acute Pulmonary Embolism with Catheter Directed Thrombolysis

The presentation of acute pulmonary thromboembolism (PE) can be highly variable resulting in diagnostic challenges and management difficulties. Current guidelines suggest that therapy must be adjusted based on the severity of PE presentation. Systemic thrombolysis is the standard therapy for acute massive pulmonary embolism (PE), however systemic thrombolysis carries an estimated 20% risk of major hemorrhage, including a 3%-5% risk of hemorrhagic stroke. There are data supporting the use of catheter directed therapy (CDT) in massive and sub-massive PE, but past studies have limited its use to patients in whom systemic thrombolysis has either failed or was contraindicated.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research